DESPITE THE FACT THAT THERE IS CURRENTLY CLEAR HYPERTENSION TREATMENT STRATEGY, WHY DOES BP CONTROL RATES REMAIN POOR WORLDWIDE?

dc.contributor.author	Bositkhonov Akmalkhon Nosirkhon ugli
dc.contributor.author	Ruzmetova Shakhnoza Davronbekovna
dc.date.accessioned	2025-12-29T17:56:08Z
dc.date.issued	2023-12-31
dc.description.abstract	Despite the fact that the causes of hypertension have been studied at the molecular level and precise treatment strategies have been developed, the level of blood pressure control remains low worldwide. What could be the reason? This article is about that.
dc.format	application/pdf
dc.identifier.uri	https://webofjournals.com/index.php/5/article/view/619
dc.identifier.uri	https://asianeducationindex.com/handle/123456789/23861
dc.language.iso	eng
dc.publisher	Web of Journals Publishing
dc.relation	https://webofjournals.com/index.php/5/article/view/619/601
dc.rights	https://creativecommons.org/licenses/by-nc-nd/4.0
dc.source	Web of Medicine: Journal of Medicine, Practice and Nursing ; Vol. 1 No. 9 (2023): WOM; 66-68
dc.source	2938-3765
dc.subject	Hypertension,blood pressure, Poor adherence, White-coat phenomenon, Marked brachial artery calcification, Clinician inertia, Lifestyle factors.
dc.title	DESPITE THE FACT THAT THERE IS CURRENTLY CLEAR HYPERTENSION TREATMENT STRATEGY, WHY DOES BP CONTROL RATES REMAIN POOR WORLDWIDE?
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/publishedVersion
dc.type	Peer-reviewed Article

item.page.files

pagination.showing.labelpagination.showing.detail

item.page.filesection.name: ugli_2023_despite_the_fact_that_there_is_currently.pdf
item.page.filesection.size: 306.95 KB
item.page.filesection.format: Adobe Portable Document Format